HCW Biologics share price logo

HCW Biologics

NASDAQ: HCWB

$1.60

+0.07

(+4.58%)

as on

HCW Biologics Stock Performance

as on October 12, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.52
    $1.73
    downward going graph

    5.00%

    Downside

    8.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.50
    $27.57
    downward going graph

    6.25%

    Downside

    1623.13%

    Upside

    downward going graph

HCW Biologics share price movements today

Previous Close
$1.53
Open
$1.60
Volume
957.8K
Market Cap
$3.4M
Day's Low - High
$1.52 - $1.73
52 Week Low - High
$1.50 - $27.57

HCW Biologics Historical Returns

1 Month Return
-34.16 %
3 Month Return
-64.84 %
1 Year Return
-93.43 %
3 Year Return
-99.67 %
5 Year Return
-99.77 %

HCW Biologics Stock Fundamentals & Key Indicators

Check HCW Biologics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.4M

EPS (TTM)

-54.17

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.03

Industry PE ratio

-2.34

PEG Ratio

0.00

EBITDA

-4.3M

Revenue (TTM)

6.7M

Profit Margin

95.91%

Return On Equity TTM

-142.16%

HCW Biologics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of HCW Biologics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
HCW Biologics image
HCW Biologics
Buy$3.4M-99.77%-0.0395.91%0.00%
Moderna image
Moderna
Neutral$78.6B-26.21%-24.69-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$127.6B185.06%29.0686.04%0.00%
Regeneron image
Regeneron
Buy$76.4B35.73%17.6684.86%0.50%

Stock Returns calculator for HCW Biologics Stock including INR - Dollar returns

The HCW Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

HCW Biologics investment value today

Current value as on today

₹7,169

Returns

-₹92,831

(-92.83%)

Returns from HCW Biologics Stock

-₹93,432 (-93.43%)

Dollar Impact

₹601 (+0.60%)

Analyst Recommendation on HCW Biologics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for HCW Biologics. Average target price of $48

HCW Biologics Share Price Target

Get share price movements and forecasts by analysts on HCW Biologics.

What analysts predicted

96.67%UPSIDE

Target Price

$48

Current Price

$1.6

Analyzed by

8 Analysts

Target

$48.00

HCW Biologics target price $48, a slight upside of 96.67% compared to current price of $1.6. According to 8 analysts rating.

Indian Investors' Interest in HCW Biologics Stock

Search interest for HCW Biologics Stock has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:60% versus previous 30 day period

HCW Biologics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
1
1
0
0
0
0
0
0
6
0
Gross Profit
-4
0
0
0
0
0
0
0
6
0
Operating Income
-10
-7
-15
-3
-3
-1
-3
-3
3
-3
EBITDA
-10
-7
-14
-3
-1
-1
-1
-4
3
-4
Interest Expense
-
-
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-7
-15
-3
-3
-2
-1
-4
3
-5
Income Tax Expense
-
-
-
-
-
-
-
-
0
-
Net Income
-10
-7
-15
-3
-3
-2
-1
-4
4
-5
Net Profit Margin
-377.44%
54.56%
29.15%
20.00%
20.00%
20.00%
20.00%
20.00%
99.83%
-69.25%

HCW Biologics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Mar 2026
Total Revenue
-
4
-
6
2
2
0
Gross Profit
0
4
-
2
0
0
0
Operating Income
-7
-5
-13
-15
-25
-29
-11
EBITDA
-6
-5
-12
-14
-23
-27
-5
Interest Expense
-
-
-
0
0
1
1
Depreciation
0
0
0
0
1
1
1
Income Before Tax
-7
-5
-12
-14
-24
-30
-7
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-7
-5
-12
-14
-24
-30
-7
Net Profit Margin
0.00%
100.00%
0.00%
38.48%
19.72%
37.38%
20.00%

HCW Biologics Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-10
-7
-15
-3
-3
-2
-1
-4
3
-5
Operating Cash Flow
-3
-3
-4
-2
-2
-3
-3
-3
-1
-3
Investing Cash Flow
-3
0
0
0
0
-
-
-
-
-
Financing Cash Flow
0
4
1
2
6
0
4
1
0
3
Change in Cash
-7
0
-2
0
3
-3
1
-1
0
0

HCW Biologics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Mar 2026
Net Income
-7
-5
-12
-14
-24
-30
-7
Operating Cash Flow
-6
-10
-10
-10
-22
-14
-13
Investing Cash Flow
-1
0
-35
14
3
0
-
Financing Cash Flow
13
11
49
6
0
15
10
Change in Cash
5
1
3
10
-18
1
-2

Global Institutional Holdings in HCW Biologics

Check out the Institutions with significant holdings in HCW Biologics.

Funds
Holdings
Fidelity Concord Street Trust
0.57%
VANGUARD INDEX FUNDS
0.54%
Vanguard
0.09%

HCW Biologics News & Key Events

  • img

    Today's Timeline - 24 September

    Thu, 07:04 PM

    -

    HCW Biologics announces $1.5 million financing through a private placement of 903,614 units to support working capital and clinical development.

Insights on HCW Biologics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 123.3% return, outperforming this stock by 222.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 832.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, HCWB stock has moved down by -28.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 4.13M → -5.21M (in $), with an average decrease of 226.3% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.54M → 135.56K (in $), with an average decrease of 97.9% per quarter

About HCW Biologics

HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patients with a variety of cancers, such as pancreatic, ovarian, breast, prostate, and colorectal, as well as for pulmonary fibrosis. Another key product, HCW9302, targets autoimmune conditions like alopecia areata and various metabolic disorders. Beyond these, HCW Biologics is also developing HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of relapsed/refractory acute myeloid leukemia. Additionally, HCW9206 is under development specifically for acute myeloid leukemia. Incorporated in 2018, the company's corporate headquarters are situated in Miramar, Florida.
OrganisationHCW Biologics
Headquarters2929 North Commerce Parkway, Miramar, FL, 33025, US
IndustryBiotechnology
CEOHing C. Wong

Key Management of HCW Biologics

Name

Title

Dr. Peter Rhode Ph.D.

Chief Scientific Officer & VP of Clinical Operations

Ms. Nicole Valdivieso Esq., J.D.

Vice President of Legal Affairs

Mr. Lee D. Flowers

Senior Vice President of Business Development

Dr. Hing C. Wong Ph.D.

Founder, CEO, Director & Secretary

FAQs

What is HCW Biologics share price today?

HCW Biologics share price today is $1.60 as on at the close of the market. HCW Biologics share today touched a day high of $1.73 and a low of $1.52.

What is the 52 week high and 52 week low for HCW Biologics share?

HCW Biologics share touched a 52 week high of $27.57 on and a 52 week low of $1.50 on . HCW Biologics stock price today i.e. is closed at $1.60,which is 94.20% down from its 52 week high and 6.67% up from its 52 week low.

What is HCW Biologics's market capitalisation today?

HCW Biologics market capitalisation is $0.00T as on .

How to invest in HCW Biologics Stock (HCWB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for HCW Biologics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy HCW Biologics Stock (HCWB) from India?

Indian investors can start investing in HCW Biologics (HCWB) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in HCW Biologics stock (as per the Rupee-Dollar exchange rate as on ). Based on HCW Biologics share’s latest price of $1.60 as on October 12, 2026 at 8:45 am IST, you will get 6.2500 shares of HCW Biologics. Learn more about fractional shares .

What are the returns that HCW Biologics has given to Indian investors in the last 5 years?

HCW Biologics stock has given -99.77% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?